Xyrem sodium oxybate oral solution regulatory update

The FDA granted marketing approval to ORPH for its Xyrem to treat cataplexy, a sudden loss of muscle tone associated with narcolepsy. The company plans to launch Xyrem at the start of next quarter. In...